As difficult-to-treat infections continue to rise, phage therapies are becoming important complements to existing treatments.

Cimzia® is a registered trademark of UCB Pharma S.A.

Eli Lilly's portfolio, both within and outside its core area, makes the stock attractive. However, a recent move Eli Lilly made reveals an underrated reason why the stock has attractive prospects.

Medicamen Organics Limited has announced impressive financial results for FY25, showcasing strong performance across key ...

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global ...

The medical diagnostics company filed for bankruptcy protection to reorganize its debts, facing high litigation costs.

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

The new data shows there were some 143,000 life science jobs in 2024, an increase of just 0.03% from 2023, according to the ...

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways ...